Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Acceptability and efficacy of vaginal self-sampling for genital infection and bacterial vaginosis: A large, cross-sectional, non-inferiority trial

Camus Claire, View ORCID ProfilePenaranda Guillaume, Khiri Hacène, Camiade Sabine, Molet Lucie, Lebsir Melissa, Plauzolles Anne, Chiche Laurent, Blanc Bernard, Quarello Edwin, Halfon Philippe
doi: https://doi.org/10.1101/2021.01.05.21249269
Camus Claire
1Clinical Research and R&D Department, Laboratoire Européen Alphabio, 13003 Marseille, France
2FCRIN INSERM US015, CHU de Toulouse, Hôpital PURPAN, 31059 Toulouse, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Penaranda Guillaume
1Clinical Research and R&D Department, Laboratoire Européen Alphabio, 13003 Marseille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Penaranda Guillaume
Khiri Hacène
1Clinical Research and R&D Department, Laboratoire Européen Alphabio, 13003 Marseille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Camiade Sabine
3Bacteriology Department, Laboratoire Européen Alphabio, 13003 Marseille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Molet Lucie
1Clinical Research and R&D Department, Laboratoire Européen Alphabio, 13003 Marseille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lebsir Melissa
3Bacteriology Department, Laboratoire Européen Alphabio, 13003 Marseille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Plauzolles Anne
1Clinical Research and R&D Department, Laboratoire Européen Alphabio, 13003 Marseille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chiche Laurent
4Infectious and Internal Medicine Department, Hôpital Européen Marseille, 13003 Marseille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Blanc Bernard
5Gynecology Department, Hôpital Européen Marseille, 13003 Marseille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Quarello Edwin
6Prenatal Screening and Diagnostic Unit, Obstetrics and Gynecology Department, St Joseph Hospital, 13285 Marseille, France
7Image2 Center, 13008 Marseille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Halfon Philippe
1Clinical Research and R&D Department, Laboratoire Européen Alphabio, 13003 Marseille, France
4Infectious and Internal Medicine Department, Hôpital Européen Marseille, 13003 Marseille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: philippe.halfon@alphabio.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objective Screening for genital infection (GI), bacterial vaginosis (BV), sexually transmitted infection (STI) and asymptomatic carriage of group B streptococcus (GBS) in pregnant women is a common reason for medical appointments. Objectives were first to determine the non-inferiority of vaginal self-sampling compared with vaginal/cervical classical sampling to screen for GIs, bacterial vaginosis (BV), STIs, and GBS asymptomatic carriage in pregnant women; second to determine the feasibility of vaginal self-sampling.

Methods Vaginal self-sampling (VSS) and vaginal/cervical classical sampling (VCS) of 1027 women were collected by health care professionals and simultaneously carried out on each patient. Bacterial infection, yeast infection, Chlamydia trachomatis, Neisseria gonorrhoea, Mycoplasma genitalium, Trichomonas vaginalis and Herpes simplex virus types were systematically screened in both paired VSS and VCS samples.

Results Statistical tests supported the non-inferiority of VSS compared with VCS. Agreements between VCS and VSS remained high regardless of the type of studied infection. VSS had successful diagnostic performances, especially for Predictive negative value (PNV) (over 90%) for all studied infections. Most participants (84%) recommended the use of VSS.

Conclusions This study remains the most exhaustive in screening for GI, BV, STI agents and asymptomatic GBS carriage. Given its efficacy and acceptability, VSS seems to be a viable alternative to classic physician sampling among women in the general population. This study provides evidence that vaginal self-sampling can be used as a universal specimen for detection of lower genital tract infections in women.

Study Identification number ID-RCB 2014-A01250-4

  • Vaginal self-sampling
  • STI
  • genital infection
  • Group B streptococcus
  • gynaecological monitoring

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

ID-RCB 2014-A01250-4

Funding Statement

This work was supported by European Alphabio Laboratory and European Hospital of Marseille and two industrial companies, Roche Molecular Systems, Inc., and BioMerieux, for providing reagents. Roche Molecular Systems, Inc., supported Claire Camus for the preliminary presentation at the ECCMID congress 2017. The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing the report. The corresponding author had full access to all study data and had final responsibility to submit for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This biomedical clinical study was authorised by the French competent authority (ANSM, www.ansm.sante.fr) and received the agreement of an ethics committee (CPP Sud Mediterranee I). The French national identification number of the study is ID-RCB 2014-A01250-47.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • FUNDING: This work was supported by European Alphabio Laboratory and European Hospital of Marseille and two industrial companies, Roche Molecular Systems, Inc., and BioMérieux, for providing reagents. Roche Molecular Systems, Inc., supported Claire Camus for the preliminary presentation at the ECCMID congress 2017. The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing the report. The corresponding author had full access to all study data and had final responsibility to submit for publication.

  • COMPETING INTEREST STATEMENT: All authors have completed the Unified Competing Interest form and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work.

  • TRANSPARENCY DECLARATION: The manuscript is an honest, accurate, and transparent account of the study being reported. No important aspects of the study have been omitted; and any discrepancies from the study as planned have been explained.

Data Availability

Data will be available to researchers who provide a methodologically sound proposal. Requests should be addressed by email to g.penaranda{at}alphabio.fr

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted January 06, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Acceptability and efficacy of vaginal self-sampling for genital infection and bacterial vaginosis: A large, cross-sectional, non-inferiority trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Acceptability and efficacy of vaginal self-sampling for genital infection and bacterial vaginosis: A large, cross-sectional, non-inferiority trial
Camus Claire, Penaranda Guillaume, Khiri Hacène, Camiade Sabine, Molet Lucie, Lebsir Melissa, Plauzolles Anne, Chiche Laurent, Blanc Bernard, Quarello Edwin, Halfon Philippe
medRxiv 2021.01.05.21249269; doi: https://doi.org/10.1101/2021.01.05.21249269
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Acceptability and efficacy of vaginal self-sampling for genital infection and bacterial vaginosis: A large, cross-sectional, non-inferiority trial
Camus Claire, Penaranda Guillaume, Khiri Hacène, Camiade Sabine, Molet Lucie, Lebsir Melissa, Plauzolles Anne, Chiche Laurent, Blanc Bernard, Quarello Edwin, Halfon Philippe
medRxiv 2021.01.05.21249269; doi: https://doi.org/10.1101/2021.01.05.21249269

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (453)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (158)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5275)
  • Forensic Medicine (3)
  • Gastroenterology (198)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (700)
  • Health Policy (361)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (164)
  • Infectious Diseases (except HIV/AIDS) (5905)
  • Intensive Care and Critical Care Medicine (364)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (769)
  • Nursing (43)
  • Nutrition (132)
  • Obstetrics and Gynecology (144)
  • Occupational and Environmental Health (234)
  • Oncology (481)
  • Ophthalmology (153)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2028)
  • Radiology and Imaging (351)
  • Rehabilitation Medicine and Physical Therapy (159)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)